Adagio Medical Holdings Statistics
Total Valuation
ADGM has a market cap or net worth of $16.55 million. The enterprise value is $27.73 million.
| Market Cap | 16.55M |
| Enterprise Value | 27.73M |
Important Dates
The last earnings date was Tuesday, May 12, 2026, before market open.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ADGM has 22.21 million shares outstanding. The number of shares has increased by 76.89% in one year.
| Current Share Class | 22.21M |
| Shares Outstanding | 22.21M |
| Shares Change (YoY) | +76.89% |
| Shares Change (QoQ) | +10.26% |
| Owned by Insiders (%) | 1.36% |
| Owned by Institutions (%) | 6.78% |
| Float | 4.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 82.73 |
| PB Ratio | 2.89 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 4.21.
| Current Ratio | 1.85 |
| Quick Ratio | 1.51 |
| Debt / Equity | 4.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.52 |
Financial Efficiency
Return on equity (ROE) is -268.88% and return on invested capital (ROIC) is -40.49%.
| Return on Equity (ROE) | -268.88% |
| Return on Assets (ROA) | -30.52% |
| Return on Invested Capital (ROIC) | -40.49% |
| Return on Capital Employed (ROCE) | -64.07% |
| Weighted Average Cost of Capital (WACC) | 7.15% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$594,293 |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | 0.22 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.43% in the last 52 weeks. The beta is -0.20, so ADGM's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | -39.43% |
| 50-Day Moving Average | 1.04 |
| 200-Day Moving Average | 1.16 |
| Relative Strength Index (RSI) | 37.39 |
| Average Volume (20 Days) | 110,179 |
Short Selling Information
The latest short interest is 63,955, so 0.29% of the outstanding shares have been sold short.
| Short Interest | 63,955 |
| Short Previous Month | 40,990 |
| Short % of Shares Out | 0.29% |
| Short % of Float | 1.34% |
| Short Ratio (days to cover) | 0.52 |
Income Statement
| Revenue | n/a |
| Gross Profit | -431,000 |
| Operating Income | -19.69M |
| Pretax Income | -24.37M |
| Net Income | -24.37M |
| EBITDA | -18.78M |
| EBIT | -19.69M |
| Earnings Per Share (EPS) | -$1.33 |
Balance Sheet
The company has $12.91 million in cash and $24.09 million in debt, with a net cash position of -$11.18 million or -$0.50 per share.
| Cash & Cash Equivalents | 12.91M |
| Total Debt | 24.09M |
| Net Cash | -11.18M |
| Net Cash Per Share | -$0.50 |
| Equity (Book Value) | 5.73M |
| Book Value Per Share | 0.26 |
| Working Capital | 7.28M |
Cash Flow
In the last 12 months, operating cash flow was -$15.93 million and capital expenditures -$41,000, giving a free cash flow of -$15.97 million.
| Operating Cash Flow | -15.93M |
| Capital Expenditures | -41,000 |
| Depreciation & Amortization | 909,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -15.97M |
| FCF Per Share | -$0.72 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADGM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -76.89% |
| Shareholder Yield | -76.89% |
| Earnings Yield | -147.26% |
| FCF Yield | -96.51% |
Analyst Forecast
The average price target for ADGM is $3.33, which is 346.98% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.33 |
| Price Target Difference | 346.98% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |